• Profile
Close

Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children

Pediatric Nephrology Sep 09, 2017

Raymakers-Janssen PAMA, et al. - A prospective study was conducted on using citrate in continuous renal replacement therapy (CRRT) in critically ill small children. The authors concluded that use of regional citrate significantly prolonged circuit survival time. They ought to increase CRRT efficiency when compared to heparin. Moreover, in critically ill small children, citrate appeared safe for CRRT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay